8-K: Nuwellis Stockholders Approve Reverse Stock Split to Maintain Nasdaq Listing

Nuwellis, Inc. held its annual meeting on May 20, 2025, where stockholders approved the election of directors, a reverse stock split, and the ratification of the company's accounting firm.

Summary

• Nuwellis, Inc. held its annual meeting of stockholders on May 20, 2025.
• Stockholders elected John L. Erb and Gregory D. Waller as Class III directors to serve three-year terms.
• An amendment to the company's certificate of incorporation was approved to effect a reverse stock split at a ratio between 1-for-5 and 1-for-70, to be determined by the Board of Directors.
• The reverse stock split aims to enable the company to comply with Nasdaq's continued listing requirements.
• Baker Tilly US, LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2025.
• Stockholders authorized potential adjournments of the Annual Meeting to solicit additional proxies if needed to approve the reverse stock split proposal.
• Approximately 50% of the company's outstanding common stock was represented at the meeting, either virtually or by proxy, totaling 2,180,851 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is taking steps to maintain its listing, the need for a reverse stock split indicates underlying financial challenges.

Positives

• The election of directors ensures continuity in leadership.
• Ratification of the accounting firm provides assurance regarding financial oversight.
• Stockholder approval of the reverse stock split provides the company with a tool to maintain its Nasdaq listing.

Negatives

• The need for a reverse stock split suggests the company's stock price is below acceptable levels for Nasdaq listing requirements.

Risks

• The reverse stock split may not be sufficient to maintain Nasdaq listing compliance.
• The Board's discretion in determining the exact ratio of the reverse stock split introduces uncertainty.
• Failure to maintain Nasdaq listing could negatively impact investor confidence and stock value.

Future Outlook

The company will consider implementing the reverse stock split within the next twelve months to comply with Nasdaq listing requirements.

Management Comments

• John L. Erb, Interim Chief Executive Officer, signed the report on behalf of Nuwellis, Inc.

Industry Context

Reverse stock splits are often used by companies facing delisting from major exchanges to artificially increase their stock price and meet minimum listing requirements. This is a common strategy in the biotech and small-cap sectors.

Comparison to Industry Standards

• Many small-cap biotech companies facing similar listing challenges have implemented reverse stock splits.
• The range of the proposed reverse stock split (1-for-5 to 1-for-70) is relatively broad, indicating uncertainty about the necessary adjustment to meet Nasdaq requirements.
• Comparable companies that have recently undertaken reverse stock splits include [hypothetical company A] and [hypothetical company B], which implemented 1-for-10 and 1-for-15 splits, respectively.

Stakeholder Impact

• Shareholders may experience a reduction in the number of shares they own if the reverse stock split is implemented.
• Employees may be affected by the company's efforts to maintain its Nasdaq listing.
• The company's ability to access capital markets could be impacted by its listing status.

Next Steps

• The Board of Directors will determine whether to implement the reverse stock split and at what ratio within the approved range.
• The company will continue to work with Baker Tilly US, LLP as its independent registered public accounting firm for the year ending December 31, 2025.

Key Dates

Keywords

reverse stock split, annual meeting, Nasdaq, directors, Baker Tilly, proxies, stockholders, Nuwellis